Product Images Rabeprazole Sodium
View Photos of Packaging, Labels & Appearance
- rabeprazole fig1
- FIGURE 2: MEAN DAYTIME HEARTBURN SCORES RAB-USA-2 - rabeprazole fig2
- FIGURE 3: MEAN NIGHTTIME HEARTBURN SCORES RAB-USA-2 - rabeprazole fig3
- FIGURE 4: MEAN DAYTIME HEARTBURN SCORES RAB-USA-3 - rabeprazole fig4
- FIGURE 5: MEAN NIGHTTIME HEARTBURN SCORES RAB-USA-3 - rabeprazole fig5
- Chemical Structure - rabeprazole str
Product Label Images
The following 6 images provide visual information about the product associated with Rabeprazole Sodium NDC 65862-721 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
rabeprazole fig1
The text provides mean scores for different treatments on heartburn among a sample of 68 people on placebo, 64 people on RAB 10mg, and 67 people on RAB 20mg. The heartburn scores are rated on a scale of 0 to 4, with 0 indicating no heartburn, and 4 indicating very severe heartburn. This information can be useful for evaluating the effectiveness of these treatments in reducing heartburn symptoms.*
FIGURE 2: MEAN DAYTIME HEARTBURN SCORES RAB-USA-2 - rabeprazole fig2
This text appears to be a report or data summary from a study about the effectiveness of a placebo and two different doses of a medication called RAB in reducing heartburn symptoms. The number of participants in each group is given (n=64 for RAB10mg and n=67 for RAB20mg). The heartburn scores are also mentioned, with 0 indicating no heartburn and 1-4 indicating increasing severity. The scores were recorded on study days 7, 14, 21, and 28.*
FIGURE 3: MEAN NIGHTTIME HEARTBURN SCORES RAB-USA-2 - rabeprazole fig3
This text presents mean score data for a study comparing a placebo group to a group taking RAB 20mg. The study included 58 participants in the placebo group and 59 in the RAB 20mg group. The study looks at heartburn scores on different days and categorizes them as None, Slight, Moderate, Severe, and Very Severe.*
FIGURE 4: MEAN DAYTIME HEARTBURN SCORES RAB-USA-3 - rabeprazole fig4
This appears to be a chart or table showing heartburn scores for a study comparing a placebo to a medication called RAB20mg. The scores range from 0 to 4, with 0 indicating no heartburn and 4 indicating very severe heartburn. However, there is not enough context to provide more detail on the study or its significance.*
FIGURE 5: MEAN NIGHTTIME HEARTBURN SCORES RAB-USA-3 - rabeprazole fig5
This is a description of Rabeprazole Sodium delayed-release tablets. Each tablet has 20mg of Rabeprazole sodium USP, and the recommended dosage is stated in the accompanying prescribing information. Pharmacists are to give each patient a medication guide. The tablets come in a bottle of 30 and should be stored at room temperature, protected from moisture. The distributor of the medication is Aurobindo Pharma USA, Inc., and the medication was made in India. The NDC for the medication is 65862-721-30.*
Chemical Structure - rabeprazole str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
